With the NASH pipeline filling up fast, Mariel Metcalfe looks at what pharma companies need to do to ensure their products do not end up as also-rans in this dynamic new market segment.
Mariel Metcalfe
Advertisement
Mariel Metcalfe is Head of Living With at Research Partnership.
Articles by Mariel Metcalfe
Advertisement
Latest Updated Articles
NASH: Pointers for Pharma from the Patient PerspectiveOctober 3rd 2017
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $7.8 Billion Agreement to Acquire Centessa Pharmaceuticals to Advance Sleep-Wake Treatments
2
Novo Nordisk Launches Multi-Month Subscription Program for Wegovy
3
Merck Enters $838 Million Research & Development Collaboration with Infinimmune
4
How Will MFN’s Effects on Medicare Impact Innovation?
5